Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer

This retrospective study aimed at evaluating the prognostic impact of high serum levels of either the HER-2 extracellular domain (ECD) or the epidermal growth factor receptor (EGFR) ECD measured using two specific ELISAs in 221 patients with non-small-cell lung cancer (NSCLC) receiving conventional...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacot, W, Pujol, J-L, Boher, J-M, Lamy, P-J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409859/
https://www.ncbi.nlm.nih.gov/pubmed/15226769
http://dx.doi.org/10.1038/sj.bjc.6601987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409859/
https://www.ncbi.nlm.nih.gov/pubmed/15226769
http://dx.doi.org/10.1038/sj.bjc.6601987

Ejemplares similares